BrightPath Biotherapeutics Co., Ltd.

Corporate Details

ISIN(s):

N/A

LEI:

Country:

Japan

Address:

川崎市川崎区殿町三丁目２５番２２号

Website:

https://www.brightpathbio.com/english/

Sector:

Health Care

Industry:

Pharmaceuticals

Description

BrightPath Biotherapeutics Co., Ltd. is a pioneering Japanese biotechnology company specializing in innovative cancer therapies. The company focuses on developing iPS-NKT, a groundbreaking allogeneic cell therapy that utilizes induced pluripotent stem cells (iPSCs) to generate natural killer T-cells (NKT cells) for cancer treatment. Recognizing the therapeutic potential of NKT cells, which exhibit diverse anti-tumor effects yet are typically scarce in the bloodstream, BrightPath harnesses state-of-the-art iPSC technology to produce these cells in large, homogeneous quantities from its iPS Master Cell Bank. By leveraging this novel approach, BrightPath aims to advance cancer treatment and improve patient outcomes through effective and scalable cell therapies.